Cargando…

Stem cell therapies : opportunities for ensuring the quality and safety for clinical offerings : summary of a joint workshop by the Institute of Medicine, the National Academy of Sciences, and the International Society for Stem Cell Research /

"Stem cells offer tremendous promise for advancing health and medicine. Whether being used to replace damaged cells and organs or else by supporting the body's intrinsic repair mechanisms, stem cells hold the potential to treat such debilitating conditions as Parkinson's disease, diab...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: Stem Cell Therapies: Opportunities for Ensuring the Quality and Safety of Unregulated Clinical Offerings (Workshop) Washington, D.C.)
Otros Autores: Berger, Adam C. (rapporteur.), Beachy, Sarah H. (rapporteur.), Olson, Steve, 1956- (rapporteur.)
Formato: Electrónico Congresos, conferencias eBook
Idioma:Inglés
Publicado: Washington, D.C. : The National Academies Press, [2014]
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_ocn887933136
003 OCoLC
005 20240329122006.0
006 m o d
007 cr |n|||||||||
008 140815t20142014dcua oab 100 0 eng d
040 |a YDXCP  |b eng  |e rda  |e pn  |c YDXCP  |d OCLCO  |d E7B  |d CUS  |d N$T  |d OCLCQ  |d CDS  |d OCLCQ  |d EBLCP  |d DEBSZ  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCA  |d AGLDB  |d ZCU  |d MERUC  |d OCLCQ  |d MERER  |d OCLCQ  |d OCLCO  |d OCLCA  |d BUF  |d OCLCF  |d OCLCO  |d VNS  |d OCLCO  |d VTS  |d ICG  |d OCLCO  |d OCLCQ  |d REC  |d STF  |d OCLCO  |d DKC  |d OCLCQ  |d M8D  |d OCLCQ  |d OCLCO  |d SFB  |d OCL  |d OCLCQ  |d OCLCO  |d OCLCL 
019 |a 884590397  |a 923290831 
020 |a 030930301X  |q (electronic bk.) 
020 |a 9780309303019  |q (electronic bk.) 
020 |z 9780309303002 
020 |z 0309303001 
029 1 |a DEBBG  |b BV042795742 
029 1 |a DEBBG  |b BV044056165 
029 1 |a DEBSZ  |b 429935633 
029 1 |a DEBSZ  |b 452582075 
035 |a (OCoLC)887933136  |z (OCoLC)884590397  |z (OCoLC)923290831 
050 4 |a QH588.S83  |b S74 2013 
060 4 |a QU 325 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616.02/774  |2 23 
049 |a UAMI 
111 2 |a Stem Cell Therapies: Opportunities for Ensuring the Quality and Safety of Unregulated Clinical Offerings (Workshop)  |d (2013 :  |c Washington, D.C.) 
245 1 0 |a Stem cell therapies :  |b opportunities for ensuring the quality and safety for clinical offerings : summary of a joint workshop by the Institute of Medicine, the National Academy of Sciences, and the International Society for Stem Cell Research /  |c Adam C. Berger, Sarah H. Beachy, and Steve Olson, rapporteurs ; Board on Health Sciences Policy, Institute of Medicine ; Board on Life Sciences, Division on Earth and Life Studies, Institute of Medicine and National Research Council of the National Academies. 
264 1 |a Washington, D.C. :  |b The National Academies Press,  |c [2014] 
264 4 |c ©2014 
300 |a 1 online resource (xx, 87 pages) :  |b color illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references. 
505 0 |a Introduction and themes of the workshop -- Stem cell therapies: knowns and unknowns -- Patients' experiences -- Comparative regulatory and legal frameworks -- The roles of professional societies -- Moving forward. 
520 |a "Stem cells offer tremendous promise for advancing health and medicine. Whether being used to replace damaged cells and organs or else by supporting the body's intrinsic repair mechanisms, stem cells hold the potential to treat such debilitating conditions as Parkinson's disease, diabetes, and spinal cord injury. Clinical trials of stem cell treatments are under way in countries around the world, but the evidence base to support the medical use of stem cells remains limited. Despite this paucity of clinical evidence, consumer demand for treatments using stem cells has risen, driven in part by a lack of available treatment options for debilitating diseases as well as direct-to-consumer advertising and public portrayals of stem cell-based treatments. Clinics that offer stem cell therapies for a wide range of diseases and conditions have been established throughout the world, both in newly industrialized countries such as China, India, and Mexico and in developed countries such as the United States and various European nations. Though these therapies are often promoted as being established and effective, they generally have not received stringent regulatory oversight and have not been tested with rigorous trials designed to determine their safety and likely benefits. In the absence of substantiated claims, the potential for harm to patients - as well as to the field of stem cell research in general - may outweigh the potential benefits. To explore these issues, the Institute of Medicine, the National Academy of Sciences, and the International Society for Stem Cell Research held a workshop in November 2013. Stem Cell Therapies summarizes the workshop. Researchers, clinicians, patients, policy makers, and others from North America, Europe, and Asia met to examine the global pattern of treatments and products being offered, the range of patient experiences, and options to maximize the well-being of patients, either by protecting them from treatments that are dangerous or ineffective or by steering them toward treatments that are effective. This report discusses the current environment in which patients are receiving unregulated stem cell offerings, focusing on the treatments being offered and their risks and benefits. The report considers the evidence base for clinical application of stem cell technologies and ways to assure the quality of stem cell offerings."--Publisher's descriptions 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Stem cells  |x Therapeutic use  |v Congresses. 
650 0 |a Cellular therapy  |v Congresses. 
650 0 |a Cellular therapy  |x Law and legislation  |v Congresses. 
650 0 |a Stem cells. 
650 2 |a Stem Cells 
650 6 |a Cellules souches  |x Emploi en thérapeutique  |v Congrès. 
650 6 |a Thérapie cellulaire  |v Congrès. 
650 6 |a Cellules souches. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Stem cells  |2 fast 
650 7 |a Cellular therapy  |2 fast 
655 2 |a Congress 
655 7 |a proceedings (reports)  |2 aat 
655 7 |a Conference papers and proceedings  |2 fast 
655 7 |a Conference papers and proceedings.  |2 lcgft 
655 7 |a Actes de congrès.  |2 rvmgf 
700 1 |a Berger, Adam C.,  |e rapporteur. 
700 1 |a Beachy, Sarah H.,  |e rapporteur. 
700 1 |a Olson, Steve,  |d 1956-  |e rapporteur.  |1 https://id.oclc.org/worldcat/entity/E39PBJpV6yX9jFKMQMYFvVkhpP 
710 2 |a Institute of Medicine (U.S.).  |b Board on Health Sciences Policy,  |e issuing body. 
710 2 |a National Research Council (U.S.).  |b Board on Life Sciences,  |e issuing body. 
710 2 |a International Society for Stem Cell Research,  |e issuing body. 
758 |i has work:  |a Stem cell therapies (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCG83QPXX6QQv6BYpTfq4v3  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Stem Cell Therapies: Opportunities for Ensuring the Quality and Safety of Unregulated Clinical Offerings (Workshop) (2013 : Washington, D.C.).  |t Stem cell therapies.  |d Washington, D.C. : National Academies Press, [2014]  |z 0309303001  |w (OCoLC)882531315 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3379333  |z Texto completo 
936 |a BATCHLOAD 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3379333 
938 |a ebrary  |b EBRY  |n ebr10889070 
938 |a EBSCOhost  |b EBSC  |n 867671 
938 |a YBP Library Services  |b YANK  |n 11965887 
994 |a 92  |b IZTAP